Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
| Status: | Withdrawn |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | July 2005 |
| End Date: | March 2008 |
Multicenter Trial Using Multi-dose Rituximab as Induction and Desensitization Therapy for Patients on the Waiting List for Kidney Transplant With a Positive Donor Specific Crossmatch to a Living Donor
This is a study of patients who have a high risk of kidney rejection before kidney
transplant. The hypothesis is that treatment with a medication called rituximab will make it
possible for them to receive a kidney transplant from a donor who previously did not present
a good match.
transplant. The hypothesis is that treatment with a medication called rituximab will make it
possible for them to receive a kidney transplant from a donor who previously did not present
a good match.
Inclusion Criteria:
- Active status on a kidney transplant waiting list with positive cross match against a
living donor
Exclusion Criteria:
- Receipt of a live vaccine within 4 weeks prior to randomization
- Previous Treatment with Rituximab
We found this trial at
1
site
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
Click here to add this to my saved trials
